Available clinical trials are below. Click the + sign to expand and review details about their purpose, eligibility criteria, and contact information for study staff. For some studies, you will find a link to ClinicalTrials.gov, where you can explore more information about each study.

NRG-CC014

Study Phase: Phase III

Condition(s): Asymptomatic, high-risk bone metastases from any solid tumor, excluding multiple myeloma
NRG CC014: Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Mulitcenter Randomized Phase 3 Clinical Trial (PREEMPT)

ClinicalTrials.gov NCT ID: NCT06745024

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
profile_amy-grossman

Amy Grossman, RN

Primary Contact - Study Coordinator

484-658-1788
amy.grossman@sluhn.org

profile_william-smith

William H. Smith, MD

Physician - Principal Investigator

NRG-GY037

Study Phase: Phase III

Condition(s): Stage III – IVA locally advanced cervical cancer
A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembrolizumab vs Chemoradiation and Pembrolizumab Both Followed by Pembrolizumab for High Risk Locally Advanced Cervical Cancer

ClinicalTrials.gov NCT ID: NCT07061977

You can view the full clinical description on ClinicalTrials.gov.

View Full Description
clinical-trials-profile

Janine Schippang

Primary Contact - Study Coordinator

484-658-1790
janineL.schippang@sluhn.org

profile_sarah-huepenbecker

Sarah P. Huepenbecker, MD

Physician - Principal Investigator

To inquire if you're eligible for a clinical trial, contact: (484) 658-5080, or click here to complete a clinical trial inquiry form.

Cancer Ribbon

Transforming lives through philanthropy

Supporting clinical trials and research can help us create a future where advanced health care is accessible and equitable for everyone. Together, we can transform lives and improve health care for generations to come.

Donate today